Until delivery of Sputnik V is standardized, vaccine produced in India is cleared – Telam

The national government on Tuesday authorized “urgently” the vaccine against the coronavirus produced by the Serum Institute of India, a novelty which is complemented by the official expectation that in the coming days there will be a gradual normalization of the administration of doses of Sputnik V and with the arrival of vaccines made available by the Covax Global Vaccine Access Fund.

Based on the recommendations of the National Administration of Drugs, Food and Medical Technology (ANMAT), the Ministry of Health has authorized the vaccine produced in India, as published on Tuesday in resolution 627/2021 of the Official newspaper.

The vaccine has already been approved by 12 health authorities in various countries, in addition to India“

The vaccine, whose name is Covishield / ChAdOx1nCoV-19 Corona Virus Vaccine-Recombinant, “It results from the development of the production process carried out by the Serum Institute of India in collaboration with the University of Oxford and AstraZeneca as part of a technology transfer,” says the resolution.

The Ministry of Health noted that this transfer “does not impact the quality, safety and efficiency” already assessed by the Anmat when he passed the specialty developed by the University of Oxford and AstraZeneca.

For the vaccine recommendation, Anmat had “all the information as established for emergency authorization based on the standards of processing plants, product development, their certification in the country of origin and compliance with quality standards, ”official sources extended to Tlam.

More, “there were no serious adverse events nor did they identify any significant differences in the efficacy of the different age groups that took part in the clinical trials ”, underlines the resolution signed by Minister Gins Gonzlez Garca.

Sputnik V

The government plans for the next few days the gradual normalization of the delivery of Sputnik V and the arrival of vaccines ordered by the global Covax fund (promoted by the World Health Organization, WHO), after last week to know new commitments to acquire more doses of ensure coverage of the population over 18.

Likewise, over the past week, Casa Rosada highlighted the publication in the British scientific journal The Lancet of the results of phase 3 of Sputnik V, which approve of 91.6% efficacy in preventing coronavirus and they confirm that this vaccine is safe.

In the government, they expect a gradual normalization of Sputnik V deliveries in the short term and stress that there is a “bottleneck to be expected” and it affects everyone.

On the same day it was published in The Lancet, President Alberto Fernández spoke to his Russian counterpart, Vladimir Putin, who told him that “production is increased so that Argentina receives the agreed volume”.

Fernndez, in an interview published last Sunday, estimated that on February 15 the supply of doses of Sputnik V will be normalized and he expressed his hope that until March 31, Argentina will receive the amount that Russia has promised to deliver to “speed up vaccination as much as possible”.

Government aims to vaccinate 4.5 million people per month, said the president, and argued that “to speed up the application process” assesses “empower pharmacies”.

“There was clearly a delay in the forecasts that Russia had made, which should now have delivered 10 million vaccines, and the explanation they give us is that there has been a delay in production,” said the president, after noting that “the calculations show that after February 15 everything will normalize and I hope it will be so.”

Government aims to vaccinate 4.5 million people per month, President estimated“

The official goal is to complete the arrival of 30 million doses of Sputnik V, more than 22 million doses of AstraZeneca and the 2.2 million from the Covax fund. (Global initiative for access to vaccines against the coronavirus, promoted by the WHO), as confirmed by Gonzlez Garca in his presentation last Wednesday to deputies.

In addition, last week, the health quality secretary, Arnaldo Medina, assured that These 22 million doses of the vaccine developed by Oxford and AstraZeneca will be added over the next 60 days to two additional batches of 580 thousand, which will arrive between February and March.

Negotiations with Pfizer were suspended, although officials consulted by Tlam stressed that the relationship had never been severed, especially with the company’s representatives in the country.